Cornell Cancer Center

New York, New York 10065

0 studies enrolling now · 1 studies all time

What they study most

Myelodysplastic Syndromes, Other IDH1-mutated Positive Hematologic Malignancies, Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML

Studies at this site

• Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation — Recruiting now